Hear from our satisfied customers

After an extensive review of leading CDMO working with Pichia pastoris we identified VALIDOGEN as the most skilled in this area. They effectively navigated us through the secretory pathways of Pichia and provided us with several high efficiency clones meeting all our COG’s target for the expression of our therapeutic protein. They are a pleasure to work with, very committed and delivered the project on time and on cost.

Medtech Company - UK Chief Operating Officer

With a pragmatic and agile R&D approach, VALIDOGEN delivered impactful results. Their high-throughput workflows and years of experience allowed us to reach the results within budget.


Foodtech Company - France Head of R&D

Having worked on multiple projects with the VALIDOGEN team over the past 10 years, I highly recommend them in terms of successful project outcomes, quality reporting and the enthusiasm and professionalism of their team. The UNLOCK PICHIA platform has repeatedly delivered results for us in a rapid and robust manner. Notably, the production level of a key pipeline protein therapeutic increased using their platform, offering us a commercially viable route forward. Beyond this, the VALIDOGEN team are a pleasure to work with and regularly use their combined scientific acumen to go well beyond their core technologies to accommodate additional requests. An exceptional CRO in every way.

Biopharma Startup - California Senior Director of Research

VALIDOGEN is a great partner, they excel in fast and transparent communication, and their robust yeast protein expression platform delivered good yields repeatedly for multiple proteins of various origin.

Veterinary Biotech Company - the Netherlands CEO/CSO

We have been working with VALIDOGEN for quite some time. VALIDOGEN helped us speed up our development by fostering an interaction that feels more like a partnership than a service.

Foodtech Company Vice President R&D

In my role as Senior Director of Research at Promega, I've collaborated with VALIDOGEN, leveraging their UNLOCK PICHIA technology to enhance our proteomics and enzyme development projects. Their innovative approach to recombinant protein production significantly accelerated our research, showcasing the depth of their technological expertise. The interaction with the VALIDOGEN team has been outstanding, marked by their responsiveness and ability to tailor solutions to our needs. This partnership has not only propelled our scientific endeavors but also established a foundation for ongoing collaboration. VALIDOGEN's commitment to innovation has made them a highly valuable ally in our research landscape.

Promega Corporation - US Senior Director of Research